ENTA
Price
$12.73
Change
+$0.60 (+4.95%)
Updated
Nov 21 closing price
Capitalization
367.42M
79 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ENTA

Header iconENTA Comparison
Open Charts ENTABanner chart's image
Enanta Pharmaceuticals
Price$12.73
Change+$0.60 (+4.95%)
Volume$273.61K
Capitalization367.42M
ENTA Comparison Chart in %
ENTA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Moderna (NASDAQ:MRNA), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Nektar Therapeutics (NASDAQ:NKTR), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.12B. The market cap for tickers in the group ranges from 58 to 108.28B. VRTX holds the highest valuation in this group at 108.28B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -1%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 63%. OLMA experienced the highest price growth at 176%, while TPST experienced the biggest fall at -61%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -43%. For the same stocks of the Industry, the average monthly volume growth was -4% and the average quarterly volume growth was 77%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 79
Price Growth Rating: 59
SMR Rating: 91
Profit Risk Rating: 93
Seasonality Score: 7 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Nov 22, 2025
Stock price -- (ENTA: $12.73)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTA’s FA Score shows that 1 FA rating(s) are green while.

  • ENTA’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTA’s TA Score shows that 4 TA indicator(s) are bullish.

  • ENTA’s TA Score: 4 bullish, 4 bearish.

Price Growth

ENTA (@Biotechnology) experienced а +5.56% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -3.31%, and the average quarterly price growth was +62.87%.

Reported Earning Dates

ENTA is expected to report earnings on Feb 09, 2026.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENTA
Capitalization367M
EBITDA-82.41M
Gain YTD121.391
P/E RatioN/A
Revenue64.8M
Total Cash204M
Total Debt58M
FUNDAMENTALS RATINGS
ENTA: Fundamental Ratings
ENTA
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
28

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTA
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 6 days ago
73%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ENTA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICRPX25.830.35
+1.37%
VY® CBRE Real Estate A
DTCCX15.780.16
+1.02%
BNY Mellon Sust US Equity C
FMUAX15.51N/A
N/A
Federated Hermes Muni and Stock Adv A
FSAAX17.25N/A
N/A
Fidelity Advisor Asset Manager 60% A
ARGC2.50N/A
N/A
Arion Group Corp.

ENTA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with MRUS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then MRUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
+4.95%
MRUS - ENTA
50%
Loosely correlated
-0.23%
NEVPF - ENTA
44%
Loosely correlated
N/A
ORKA - ENTA
37%
Loosely correlated
+8.30%
AKRO - ENTA
35%
Loosely correlated
+0.15%
ANAB - ENTA
34%
Loosely correlated
+5.23%
More